NUAK1 and Hepatic fibrosis: Our in vitro results showed that silencing ARK5 in hepatocytes suppressed TGF-β1-induced upregulation of α-SMA and Vimentin expression, further suggesting that ARK5 mediates hepatocyte EMT during liver fibrosis.